{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:02:34Z","timestamp":1774526554838,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd009004","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T00:00:00Z","timestamp":1367280000000}}],"reference-count":84,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009004.pub2","type":"journal-article","created":{"date-parts":[[2013,4,27]],"date-time":"2013-04-27T22:58:23Z","timestamp":1367103503000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection"],"prefix":"10.1002","volume":"2013","author":[{"given":"Yun","family":"Xia","sequence":"first","affiliation":[{"name":"Beijing University of Chinese Medicine; Centre for Evidence-Based Chinese Medicine; 11 Bei San Huan Dong Lu, Chaoyang District Beijing China 100029"},{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine; Centre for Evidence-Based Chinese Medicine; 11 Bei San Huan Dong Lu, Chaoyang District Beijing China 100029"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian Ping","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine; Centre for Evidence-Based Chinese Medicine; 11 Bei San Huan Dong Lu, Chaoyang District Beijing China 100029"},{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD009004.pub2-BIB0001|cit1","first-page":"50","article-title":"Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B","volume":"15","author":"Ge","year":"2005","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0002|cit2","first-page":"161","article-title":"A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B","volume":"21","author":"Huang","year":"2004","journal-title":"Journal of Guangzhou University of Traditional Chinese Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009004.pub2-BIB0003|cit3","first-page":"45","article-title":"Clinical observation of compound phyllanthus for patients with chronic hepatitis B","volume":"30","author":"Li","year":"1998","journal-title":"Journal of New Chinese Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009004.pub2-BIB0004|cit4","first-page":"44","article-title":"Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases","volume":"9","author":"Ouyang","year":"1999","journal-title":"Chinese Journal of Traditional and Western Medicine on Liver Disease"},{"issue":"4","key":"10.1002\/14651858.CD009004.pub2-BIB0005|cit5","first-page":"165","article-title":"Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B","volume":"2","author":"Zhu","year":"2005","journal-title":"Anti Infection Pharmacy"},{"issue":"6","key":"10.1002\/14651858.CD009004.pub2-BIB0006|cit6","first-page":"368","article-title":"Phyllanthus tablets and lamivudine for chronic hepatitis B in 32 cases","volume":"16","author":"Cai","year":"2006","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine on Liver Disease"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2036.2003.01671.x","article-title":"Double-blinded placebo-controlled study of phyllanthus urinaris for the treatment of chronic hepatitis B","volume":"48","author":"Chan","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD009004.pub2-BIB0008|cit8","first-page":"59","article-title":"Compound phyllanthus tablet and Interferon for children with chronic hepatitis B in 30 cases","volume":"15","author":"Cheng","year":"2005","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine on Liver Disease"},{"issue":"5","key":"10.1002\/14651858.CD009004.pub2-BIB0009|cit9","first-page":"74","article-title":"Phyllanthusnirud Linn for patients with chronic hepatitis B virus infection","volume":"13","author":"Cui","year":"1998","journal-title":"Chinese Journal of Traditional Chinese Medicine and Pharmacy"},{"issue":"5","key":"10.1002\/14651858.CD009004.pub2-BIB0010|cit10","first-page":"332","article-title":"Phyllanthus and vidarabine for chronic hepatitis B in 34 cases","volume":"13","author":"Gu","year":"2005","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine on Digestion"},{"issue":"4","key":"10.1002\/14651858.CD009004.pub2-BIB0011|cit11","first-page":"435","article-title":"Therapeutic effect observation of adefovir dipivoxil and phyllanthus for chronic hepatitis B","volume":"29","author":"He","year":"2008","journal-title":"Sichuan Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD009004.pub2-BIB0012|cit12","first-page":"108","article-title":"Therapeutic effect observation of phyllanthus for patients with chronic hepatitis B","volume":"9","author":"Huang","year":"1993","journal-title":"Chinese Journal of Clinical Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD009004.pub2-BIB0013|cit13","first-page":"146","article-title":"Compound phyllanthus and Interferon for chronic hepatitis B","volume":"20","author":"Huang","year":"1999","journal-title":"Shanxi Journal of Traditional Chinese Medicine"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0014|cit14","first-page":"32","article-title":"Phyllanthus for patients with chronic hepatitis B in 38 cases","volume":"6","author":"Huang","year":"1999","journal-title":"Information of Traditional Chinese Medicine"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0015|cit15","first-page":"8","article-title":"Clinical observation of compound phyllanthus for asymptomatic carriers of hepatitis B","volume":"5","author":"Ma","year":"1993","journal-title":"Journal of Shanghai Traditional Chinese Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009004.pub2-BIB0016|cit16","first-page":"115","article-title":"Phyllanthus tablet and adefovir dipivoxil tablet for chronic hepatitis B in 42 cases","volume":"18","author":"Qian","year":"2008","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine on Liver Disease"},{"issue":"23","key":"10.1002\/14651858.CD009004.pub2-BIB0017|cit17","first-page":"97","article-title":"Therapeutic effect observation of phyllanthus capsule for chronic hepatitis B in 98 cases","volume":"47","author":"Song","year":"2007","journal-title":"Shandong Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD009004.pub2-BIB0018|cit18","first-page":"146","article-title":"Therapeutic effect observation of phyllanthus tablet and lamivudine for chronic hepatitis B","volume":"26","author":"Su","year":"2004","journal-title":"Hebei Journal of Chinese Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009004.pub2-BIB0019|cit19","first-page":"257","article-title":"Short-term effect of phyllanthus compound and lamivudine in treating chronic hepatitis B: an observation of 30 cases","volume":"21","author":"Tian","year":"2004","journal-title":"Journal of Guangzhou University of Traditional Chinese Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009004.pub2-BIB0020|cit20","first-page":"31","article-title":"Clinical study of phyllanthus for patients with chronic hepatitis B","volume":"10","author":"Wang","year":"2000","journal-title":"Journal of Infectious Disease Pharmacy"},{"issue":"1","key":"10.1002\/14651858.CD009004.pub2-BIB0021|cit21","first-page":"74","article-title":"Phyllanthus and adefovir dipivoxil tablets for chronic hepatitis B in 20 cases","volume":"28","author":"Wang","year":"2009","journal-title":"Herald of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009004.pub2-BIB0022|cit22","first-page":"37","article-title":"Therapeutic effect observation interferon alpha and phyllanthus capsule for chronic hepatitis B","volume":"11","author":"Yan","year":"2008","journal-title":"Journal of Clinical Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD009004.pub2-BIB0023|cit23","first-page":"451","article-title":"Therapeutic effect observation of phyllanthus for patients with chronic hepatitis B","volume":"28","author":"Zhang","year":"2006","journal-title":"Journal of Ningxia Medical College"},{"issue":"28","key":"10.1002\/14651858.CD009004.pub2-BIB0024|cit24","first-page":"60","article-title":"The effect and safety assessment of phyllanthus capsule and adefovir dipivoxil tablet for chronic hepatitis B","volume":"49","author":"Zhang","year":"2009","journal-title":"Shandong Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0025|cit25","first-page":"186","article-title":"Therapeutic effect observation of phyllanthus for patients with chronic hepatitis B","volume":"16","author":"Zhong","year":"2000","journal-title":"Journal of Clinical Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD009004.pub2-BIB0026|cit26","first-page":"10","article-title":"Clinical observation of phyllanthus on hepatitis B viral markers","volume":"2","author":"Zhu","year":"1992","journal-title":"Chinese Journal of Integrated Traditional Chinese and Western Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009004.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-8278(02)00382-3","article-title":"Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model","volume":"38","author":"Aggarwal","year":"2003","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD009004.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1211\/jpp.58.12.0001","article-title":"Phytochemicals from phyllanthus niruri Linn and their pharmacological properties: a review","volume":"58","author":"Bagalkotkar","year":"2006","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0029|cit29","first-page":"7","article-title":"Hepatitis B virus: search for plant-derived antiviral","volume-title":"Medical Plants - Their Role in Health and Biodiversity","author":"Blumberg","year":"1998"},{"issue":"8","key":"10.1002\/14651858.CD009004.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD009004.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1098-1128(199807)18:4<225::AID-MED2>3.0.CO;2-X","article-title":"A review of the plants of the genus phyllanthus: their chemistry, pharmacology, and therapeutic potential","volume":"18","author":"Calixto","year":"1998","journal-title":"Medical Research Review"},{"issue":"4","key":"10.1002\/14651858.CD009004.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0166-3542(95)00020-M","article-title":"Differential inhibition of reverse transcriptase and cellular DNA polymerase-alpha activities by Lignans isolated from Chinese herbs, phyllanthus Myrtifolius Moon, and tannins from Lonicera Japonica Thunb and Castanopsis hystrix","volume":"27","author":"Chang","year":"1995","journal-title":"Antiviral Research"},{"issue":"26","key":"10.1002\/14651858.CD009004.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children","volume":"336","author":"Chang","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009004.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000100.pub3","article-title":"Vaccines for preventing hepatitis B in health-care workers","author":"Chen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0035|cit35","first-page":"1","article-title":"The Guideline of Prevention and Treatment of Chronic Hepatitis B","volume":"12","author":"Chinese Society of Hepatology and Chinese Society of Infectious Diseases","year":"2005","journal-title":"Chinese Journal of Hepatology"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0036|cit36","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis http:\/\/ctu.dk\/tsa\/"},{"issue":"7","key":"10.1002\/14651858.CD009004.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/sim.4780060706","article-title":"Practical aspects in data monitoring: a brief review","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver EASL Clinical Practice Guidellines: Management of chronic hepatitis B Journal of Hepatology 2009 227 42","DOI":"10.1016\/j.jhep.2008.10.001"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1196\/annals.1415.044","article-title":"Thymosin alpha 1: from bench to bedside","volume":"1112","author":"Garaci","year":"2007","journal-title":"The New York Academy of Sciences"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2007.01.003","article-title":"Hepatology may have problems with putative surrogate outcome measures","volume":"46","author":"Gluud","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0042|cit42","unstructured":"Gluud C Nikolova D Klingenberg SL Alexakis N Als-Nielsen B Colli A Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2011, Issue 8. Art. No.: LIVER"},{"issue":"5","key":"10.1002\/14651858.CD009004.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1517\/14712590902911412","article-title":"From lab to bedside: emerging clinical applications of thymosin alpha 1","volume":"9","author":"Goldstein","year":"2009","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0044|cit44","doi-asserted-by":"crossref","unstructured":"Higgins J Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] The Cochrane Colloboration, 2009. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1524-4733.2009.00636.x","article-title":"Assessment of total economic burden of chronic hepatitis B-related disease in Beijing and Guangzhou, China","volume":"12","author":"Hu","year":"2009","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0046|cit46","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"7303","key":"10.1002\/14651858.CD009004.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"1","key":"10.1002\/14651858.CD009004.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ympev.2004.12.002","article-title":"Molecular phylogenetics of phyllanthaceae inferred from five genes","volume":"36","author":"Kathriarachchi","year":"2005","journal-title":"Molecular Phylogenetics and Evolution"},{"issue":"1-2","key":"10.1002\/14651858.CD009004.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jep.2005.08.048","article-title":"Comparative pharmacognostic studies of three Phyllanthus species","volume":"104","author":"Khatoon","year":"2006","journal-title":"Journal of Ethnopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD009004.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomised trials in meta-analyses","volume":"135","author":"Kjaergaard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009004.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/jcb.20611","article-title":"Antiviral effect of phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis","volume":"97","author":"Lam","year":"2006","journal-title":"Journal of Cellular Biochemistry"},{"issue":"12","key":"10.1002\/14651858.CD009004.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1046\/j.1365-2362.1996.410595.x","article-title":"Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication","volume":"26","author":"Lee","year":"1996","journal-title":"European Journal of Clinical Investigation"},{"issue":"2","key":"10.1002\/14651858.CD009004.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004790.pub2","article-title":"Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers","author":"Lee","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1440-1746.2003.03037.x","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: an update","volume":"18","author":"Liaw","year":"2003","journal-title":"Journal of Gastroenterol Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1478-3231.2005.01134.x","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update","volume":"25","author":"Liaw","year":"2005","journal-title":"Liver International"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12072-008-9080-3","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update","volume":"2","author":"Liaw","year":"2008","journal-title":"Hepatology International"},{"issue":"7","key":"10.1002\/14651858.CD009004.pub2-BIB0057|cit57","first-page":"706","article-title":"Advance in research on the thymosin preparation","volume":"23","author":"Lin","year":"2009","journal-title":"Chinese Pharmaceutical Affairs"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0058|cit58","first-page":"282","article-title":"The inhibitory effect of Chinese herb Phyllanthus on hepatitis B virus in vitro","volume":"11","author":"Liu","year":"1997","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2893.2001.00307.x","article-title":"Genus Phyllanthus for chronic hepatitis B virus infections: a systematic review","volume":"8","author":"Liu","year":"2001","journal-title":"Journal of Viral Hepatitis"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD009004.pub2-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub2","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006481.pub2","article-title":"Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status","author":"Mathew","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9128","key":"10.1002\/14651858.CD009004.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD009004.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.1840140302","article-title":"Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial","volume":"14","author":"Mutchnick","year":"1991","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD009004.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1365-2362.1997.2020749.x","article-title":"Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors","volume":"27","author":"Ott","year":"1997","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0067|cit67","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"4","key":"10.1002\/14651858.CD009004.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomised controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"1","key":"10.1002\/14651858.CD009004.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003621","article-title":"Thymosin alpha1 for chronic hepatitis B","author":"Saconato","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"35","key":"10.1002\/14651858.CD009004.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovic","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD009004.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovic","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009004.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2012.01.044","article-title":"Effectiveness of hepatitis B treatment in clinical practice","volume":"142","author":"Scaglione","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD009004.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0074|cit74","first-page":"18","article-title":"Estimation of economic burden of hepatitis B","volume":"8","author":"Shi","year":"2004","journal-title":"Chinese Primary Health"},{"issue":"1","key":"10.1002\/14651858.CD009004.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2893.2010.01274.x","article-title":"Management of chronic hepatitis B: experience from China","volume":"17","author":"Sun","year":"2010","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0076|cit76","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual forTrial Sequential Analysis (TSA) http:\/\/ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"issue":"1","key":"10.1002\/14651858.CD009004.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1073\/pnas.84.1.274","article-title":"Effects of an extract from phyllanthus niruri on hepatitis B virus and woodchuck hepatitis viruses: in vitro and in vivo studies","volume":"84","author":"Venateswaran","year":"1987","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1002\/14651858.CD009004.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0080|cit80","unstructured":"WHO 2001 Introduction of hepatitis B vaccine into childhood immunization services. Management guidelines, including information for health workers and parents www.who.int\/vaccines-documents\/DocsPDF01\/www613.pdf"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0081|cit81","unstructured":"WHO 2008 Hepatitis B. World Health Organization Fact Sheet 204 (Revised August 2008) http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/index.html"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0082|cit82","unstructured":"World Health Organization Viral hepatitis. Report by the secretariat http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA63\/A63_15-en.pdf (accessed January 2010)"},{"key":"10.1002\/14651858.CD009004.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4","key":"10.1002\/14651858.CD009004.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008960.pub2","article-title":"Phyllanthus species for chronic hepatitis B virus infection","author":"Xia","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009004.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T20:03:43Z","timestamp":1742760223000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009004.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":84,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009004.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718006065.793479827","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,30]]}}}